Preclinical antibody stops rheumatoid arthritis - European Biotechnology

Preclinical antibody stops rheumatoid arthritis  European Biotechnology

An antibody therapy that targets red blood cells (RBCs) unexpectedly showed anti-inflammatory effects and rapidly reversed rheumatoid arthritis and prevented ...